Liverpool and Arne Slot were keen on Teun Koopmeiners before his move to Juventus in the summer - with Matthijs de Ligt helping convince the midfielder to remain in Italy. Koopmeiners had ...

Former Manchester United defender Jaap Stam has claimed that summer signing Matthijs de Ligt with be a major beneficiary of Ruben Amorim’s tactics at Old Trafford. It was announced officially ...

Japanese drugmaker Eisai (OTCPK:ESAIY) (OTCPK:ESALF), Biogen's (NASDAQ:BIIB) partner for intravenous Alzheimer's therapy, Leqembi, has completed the rolling submission of a Biologics License ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Fintel reports that on October 31, 2024, Morgan Stanley downgraded their outlook for Biogen (SNSE:BIIBCL) from Overweight to Equal-Weight. There are 1,775 funds or institutions reporting positions ...

Healthcare analytics company PurpleLab joined the Network Advertising Initiative. Biogen and Neomorph announced a multi-target research collaboration to discover and develop molecular glue degraders ...

Biogen Inc. (NASDAQ:BIIB) the central nervous system disease drug developer based in Cambridge Massachusetts, reported its Q3 earnings yesterday, Wednesday, October 30. First, let's look at some ...

Biogen Inc. ( (BIIB)) has realeased its Q3 earnings. Here is a breakdown of the information Biogen Inc. presented to its investors. Biogen Inc. is a leading biotechnology company that specializes ...

Two days after Monte Rosa Therapeutics Inc. signed a molecular glue degrader deal with Novartis AG, two other companies, Biogen Inc. and Neomorph Inc., are moving forward in the same space in a ...

My name is Cynthia, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Third Quarter 2024 Earnings Call and Business Update. All lines have ...